Federal Register of Legislation - Australian Government

Primary content

Instrument 2017 No. R7/MRCC7 Schemes as made
This instrument amends the Repatriation Pharmaceutical Benefits Scheme and the MRCA Pharmaceutical Benefits Scheme to update the Repatriation Schedule of Pharmaceutical Benefits to include 2 new listings for medicine brands and increase the price of 14 currently listed items.
Administered by: Veterans' Affairs
Registered 14 Dec 2017
Tabling HistoryDate
Tabled HR05-Feb-2018
Tabled Senate05-Feb-2018
Date of repeal 02 Jan 2018
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

Australian Government

 

Veterans’ Entitlements Act 1986

Military Rehabilitation and Compensation Act 2004

 

 

Veterans’ Affairs Pharmaceutical Benefits Schemes Amendment Instrument 2017

Instrument 2017 No. R7/MRCC7

 

 

 

 

 

I, Dan Tehan, Minister for Veterans’ Affairs, approve:

(a)     under section 91 of the Veterans’ Entitlements Act 1986, the variations by the Repatriation Commission of the Repatriation Pharmaceutical Benefits Scheme in the following instrument; and

(b)     under section 286 of the Military Rehabilitation and Compensation Act 2004,  the variations by the Military Rehabilitation and Compensation Commission of the MRCA Pharmaceutical Benefits Scheme in the following instrument.

 

 

Dated this  8th  day of  December 2017

 

 

 

 

 

Dan Tehan

DAN TEHAN

 

 

 

 

 

 

 

The Repatriation Commission, under section 91 of the Veterans’ Entitlements Act 1986, makes the variations to the Repatriation Pharmaceutical Benefits Scheme in the following instrument.

 

Dated this  4th  day of  December  2017

 

The Seal of the                                                               )

Repatriation Commission                                              )  SEAL

was affixed hereto in the                                                )

presence of:                                                                    ) 

                                                                                        

Simon Lewis                           C Orme                                              MA Kelly

………………………………………………………………………………………………..

 SIMON LEWIS                        CRAIG ORME                                  Major General Mark Kelly

                                                      DSC AM CSC                                                            AO DSC

    PRESIDENT                      DEPUTY PRESIDENT                                           COMMISSIONER

 

 

 

 

 

The Military Rehabilitation and Compensation Commission, under section 286 of the Military Rehabilitation and Compensation Act 2004, makes the variations to the MRCA Pharmaceutical Benefits Scheme in the following instrument.

 

 

 

Dated this  4th   day of  December  2017

 

The Seal of the                                                                    )

Military Rehabilitation and Compensation Commission    ) SEAL

was affixed hereto in the                                                     )

presence of:                                                                         )

 

  Simon Lewis                                     C Orme                                           MA Kelly

   …………………………………………………………………………………………………………..

 SIMON LEWIS                                         CRAIG ORME                                  Major General Mark Kelly

                                                                      DSC AM CSC                                                    AO DSC

         CHAIR                                                   MEMBER                                                      MEMBER

 

 

 

 

 

 

                  BS Wolski                           Jennifer Taylor                                 T Smart

……………………………………………………………………………………………………..…

REAR ADMIRAL BRETT WOLSKI        JENNIFER TAYLOR                Air Vice-Marshal TRACY SMART

                            AM                                                                                                                       AM

                       MEMBER                                         MEMBER                                                MEMBER

EMBER

 


 

 

 

1       Name

     This instrument is the Veterans’ Affairs Pharmaceutical Benefits Schemes Amendment Instrument 2017.

 

 

2       Commencement

 

This instrument commences on 1 January 2018.

 

 

3       Authority

     This instrument is made under:

 

(a)    section 91 of the Veterans’ Entitlements Act 1986 in respect of the variations to the Repatriation Pharmaceutical Benefits Scheme in Schedule 1; and

 

(b)   section 286 of the Military Rehabilitation and Compensation Act 2004 in respect of the variations to the MRCA Pharmaceutical Benefits Scheme in Schedule 2.

 

 

4       Schedules

     Each instrument that is specified in a Schedule to this instrument is varied as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

 

 


Schedule 1-Variations to the Repatriation Pharmaceutical Benefits Scheme (Instrument 2013 No. R43)

 

Part 1 – Updating of incorporated documents and other amendments

 

[1] Schedule 1 – Incorporated Documents

 

substitute:

 

SCHEDULE 1 – INCORPORATED DOCUMENTS

The following documents are incorporated-by-reference into the Scheme in the version in which they exist on 1 January 2018:

 ·         Explanatory Notes

·         RPBS Explanatory Notes

·         PBS or Pharmaceutical Benefits Scheme

·         RPBS Schedule

Note: “RPBS Schedule” is defined to mean the Repatriation Schedule of

Pharmaceutical Benefits which is further defined.

·         Sixth Community Pharmacy Agreement

 

 

[2] Subparagraph 7(d) – conformity with standards

 

substitute:

 

       (d)                conformity with standards: no drug or therapeutic substance shall be prescribed unless it conforms with the specific or general standards as determined by the relevant Minister under the Therapeutic Goods Act 1989.

 

 

[3] Section 41 - Standards

 

substitute:

41  Standards

                     The minimum acceptable standard for a Pharmaceutical benefit is that described in the regulations under the Therapeutic Goods Act 1989 which relate to specific standards for drugs.

                         

 

[4] Section 42 – Editions of monographs and  standards

 

omit the section

 

 

[5] Section 43 – Order of precedence

 

omit the section

 

 

Part 2 – Consequential amendments

 

[6] Section 3 (Interpretation) Definition of approval number

 

omit the definition, substitute:

 

approval number means a number allotted by the Secretary or the Minister for Health under section 16 of the National Health (Pharmaceutical Benefits) Regulations 2017 to an approval under the National Health Act 1953 of a person described in the section who, under the Scheme, is a Community Pharmacist;

 

 

[7] Section 3 (Interpretation) Definition of approved electronic communication

 

omit:

 

regulation 5E of the National Health (Pharmaceutical Benefits) Regulations 1960

 

substitute:

 

section 11 of the National Health (Pharmaceutical Benefits) Regulations 2017

 

[8] Section 3 (Interpretation) Definition of approved information technology requirements

 

omit:

 

regulation 5F of the National Health (Pharmaceutical Benefits) Regulations 1960

 

substitute:

 

section 12 of the National Health (Pharmaceutical Benefits) Regulations 2017

 

 

[9] Section 3 (Interpretation) Definition of Authority Prescription Form

 

omit:

 

National Health (Pharmaceutical Benefits) Regulations 1960;

 

substitute:

 

National Health (Pharmaceutical Benefits) Regulations 2017;

 

 

[10] Section 3 (Interpretation) Definition of deferred supply authorisation

 

omit:

 

regulation 26A of the National Health (Pharmaceutical Benefits) Regulations 1960;

 

substitute:

 

section 53 of the National Health (Pharmaceutical Benefits) Regulations 2017;

 

 

[11] Section 3 (Interpretation) Definition of electronic prescription (paragraph(b))

 

omit paragraph (b)

 

substitute:

 

(b) in accordance with the appropriate form approved by the Secretary under:

  (i) subparagraph 40(2)(c)(ii) (prescriptions other than medication chart prescriptions) of the National Health (Pharmaceutical Benefits) Regulations 2017; or

 

  (ii) subsection 41(5) (medication chart prescriptions) of the National Health (Pharmaceutical Benefits) Regulations 2017.

 

 

[12] Section 3 (Interpretation)

 

insert the following definition:

 

Minister for Health means the Minister administering the National Health Act 1953;

 

 

[13] Section 3 (Interpretation) Definition of paper-based prescription

 

omit:

 

subparagraph 19(1)(a)(i), (ii) or (iii) of the National Health (Pharmaceutical Benefits) Regulations 1960

 

substitute:

 

subsection 40(2) of the National Health (Pharmaceutical Benefits) Regulations 2017

 

 

[14] Section 3 (Interpretation) Definition of repeat authorisation form

 

omit:

 

subparagraph 26(1A)(a)(i) of the National Health (Pharmaceutical Benefits) Regulations 1960.

 

substitute:

 

subparagraph 52(3)(a)(i) of the National Health (Pharmaceutical Benefits) Regulations 2017.

 

 

 

[15] Section 3 (Interpretation) Definition of Standard Prescription Form

 

omit:

 

subparagraph 19(1)(a)(i), (ii) or (iii) of the National Health (Pharmaceutical Benefits) Regulations 1960;

 

substitute:

 

subsection 40(2) of the National Health (Pharmaceutical Benefits) Regulations 2017;

 

 

[16] Section 11 - Form of prescriptions (paragraph 11(1)(a))

 

omit:

 

National Health (Pharmaceutical Benefits) Regulations 1960;

 

substitute:

 

National Health (Pharmaceutical Benefits) Regulations 2017;

 

 

[17] Section 11A - Writing of prescriptions – prescriptions other than medication chart prescriptions (paragraph 11A(1)(e))

 

omit:

 

regulation 8A of the National Health Act 1953;

 

substitute:

 

section 16 of the National Health (Pharmaceutical Benefits) Regulations 2017;

 

 

[18] Section 11A -Writing of prescriptions – prescriptions other than medication chart prescriptions (paragraph 11A(1)(i))

 

omit:

 

(as defined in the National Health (Pharmaceutical Benefits) Regulations 1960)

 

substitute:

 

(as defined in the National Health (Pharmaceutical Benefits) Regulations 2017)

 

 

[19] Section 16 - Supply of Pharmaceutical Benefits – Procedure by Community Pharmacists (the Note to the section)

 

omit:

 

National Health (Pharmaceutical Benefits) Regulations 1960.

 

substitute:

 

National Health (Pharmaceutical Benefits) Regulations 2017.

 

 

[20] Section 16AA - Supply of pharmaceutical benefit on basis of medication chart prescription (subparagraph 16AA(2)(c)(i))

 

omit:

 

regulation 8A of the National Health (Pharmaceutical Benefits) Regulations 1960;

 

substitute:

 

section 16 of the National Health (Pharmaceutical Benefits) Regulations 2017;

 

 

[21] Section 16A - When Pharmaceutical benefits may be supplied by Community Pharmacists without prescription (paragraph 16A(4)(a))

 

omit:

 

regulation 8A of the National Health (Pharmaceutical Benefits) Regulations 1960;

 

substitute:

 

section 16 of the National Health (Pharmaceutical Benefits) Regulations 2017;

 

 

[22] Section 16A - When Pharmaceutical benefits may be supplied by Community Pharmacists without prescription (subsection 16A(8))

 

omit:

 

subregulation 25(2) of the National Health (Pharmaceutical Benefits) Regulations 1960

 

substitute:

 

subsection 51(2) of the National Health (Pharmaceutical Benefits) Regulations 2017

 

 

[23] Section 45 – Keeping documents – other than for continued dispensing or medication chart prescriptions (after subsection 45(2))

 

insert, at the end of the section:

 

Note: The document may be kept in an electronic form (see subsection 12(2) of the Electronic Transactions Act 1999).

 

 

[24] Section 45A – Keeping documents – continued dispensing

 

insert, at the end of the section:

 

Note: The information may be kept in an electronic form (see subsection 12(2) of the Electronic Transactions Act 1999).

 

 

[25] Section 45B – Keeping documents – medication chart prescriptions

 

insert, at the end of the section:

 

Note: The document may be kept in an electronic form (see subsection 12(2) of the Electronic Transactions Act 1999).

 

 

 


 

 

Schedule 2-Variations to the MRCA Pharmaceutical Benefits Scheme (Instrument 2013 No. MRCC 44)

 

Part 1 – Updating of incorporated documents and other amendments

 

[1] Schedule 1 – Incorporated Documents

 

substitute:

 

SCHEDULE 1 – INCORPORATED DOCUMENTS

The following documents are incorporated-by-reference into the Scheme in the version in which they exist on 1 January 2018:

 ·         Explanatory Notes

·         RPBS Explanatory Notes

·         PBS or Pharmaceutical Benefits Scheme

·         RPBS Schedule

Note: “RPBS Schedule” is defined to mean the Repatriation Schedule of

Pharmaceutical Benefits which is further defined.

·         Sixth Community Pharmacy Agreement

 

 

[2] Subparagraph 7(d) – conformity with standards

 

substitute:

 

       (d)                conformity with standards: no drug or therapeutic substance shall be prescribed unless it conforms with the specific or general standards as determined by the relevant Minister under the Therapeutic Goods Act 1989.

 

 

 

 

[3] Section 41 - Standards

 

substitute:

41  Standards

                     The minimum acceptable standard for a Pharmaceutical benefit is that described in the regulations under the Therapeutic Goods Act 1989 which relate to specific standards for drugs.

                         

 

[4] Section 42 – Editions of monographs and  standards

 

omit the section

 

 

[5] Section 43 – Order of precedence

 

omit the section

 

 

Part 2 – Consequential amendments

 

[6] Section 3 (Interpretation) Definition of approval number

 

omit the definition, substitute:

 

approval number means a number allotted by the Secretary or the Minister for Health under section 16 of the National Health (Pharmaceutical Benefits) Regulations 2017 to an approval under the National Health Act 1953 of a person described in the section who, under the Scheme, is a Community Pharmacist;

 

 

[7] Section 3 (Interpretation) Definition of approved electronic communication

 

omit:

 

regulation 5E of the National Health (Pharmaceutical Benefits) Regulations 1960

 

substitute:

 

section 11 of the National Health (Pharmaceutical Benefits) Regulations 2017

 

 

[8] Section 3 (Interpretation) Definition of approved information technology requirements

 

omit:

 

regulation 5F of the National Health (Pharmaceutical Benefits) Regulations 1960

 

substitute:

 

section 12 of the National Health (Pharmaceutical Benefits) Regulations 2017

 

 

[9] Section 3 (Interpretation) Definition of authority prescription (paragraph(b))

 

omit:

 

National Health (Pharmaceutical Benefits) Regulations 1960;

 

substitute:

 

National Health (Pharmaceutical Benefits) Regulations 2017;

 

 

[10] Section 3 (Interpretation) Definition of Authority Prescription Form

 

omit:

 

National Health (Pharmaceutical Benefits) Regulations 1960

 

substitute:

 

National Health (Pharmaceutical Benefits) Regulations 2017

 

 

[11] Section 3 (Interpretation) Definition of deferred supply authorisation

 

omit:

 

regulation 26A of the National Health (Pharmaceutical Benefits) Regulations 1960;

 

substitute:

 

section 53 of the National Health (Pharmaceutical Benefits) Regulations 2017;

 

 

[12] Section 3 (Interpretation) Definition of electronic prescription (paragraph(b))

 

omit:paragraph (b)

 

substitute:

 

(b) in accordance with the appropriate form approved by the Secretary under:

  (i) subparagraph 40(2)(c)(ii) (prescriptions other than medication chart prescriptions) of the National Health (Pharmaceutical Benefits) Regulations 2017; or

 

  (ii) subsection 41(5) (medication chart prescriptions) of the National Health (Pharmaceutical Benefits) Regulations 2017.

 

 

[13] Section 3 (Interpretation)

 

insert the following definition:

 

Minister for Health means the Minister administering the National Health Act 1953;

 

 

[14] Section 3 (Interpretation) Definition of paper-based prescription

 

omit:

 

subparagraph 19(1)(a)(i), (ii) or (iii) of the National Health (Pharmaceutical Benefits) Regulations 1960

 

substitute:

 

subsection 40(2) of the National Health (Pharmaceutical Benefits) Regulations 2017

 

 

[15]   Section 3 (Interpretation) Definition of repeat authorisation form

 

omit:

 

subparagraph 26(1A)(a)(i) of the National Health (Pharmaceutical Benefits) Regulations 1960

 

substitute:

 

subparagraph 52(3)(a)(i) of the National Health (Pharmaceutical Benefits) Regulations 2017

 

 

[16] Section 3 (Interpretation) Definition of Standard Prescription Form

 

omit:

 

subparagraph 19(1)(a)(i), (ii) or (iii) of the National Health (Pharmaceutical Benefits) Regulations 1960;

 

substitute:

 

subsection 40(2) of the National Health (Pharmaceutical Benefits) Regulations 2017;

 

 

[17] Section 11 - Form of prescriptions (paragraph 11(1)(a))

 

omit:

 

National Health (Pharmaceutical Benefits) Regulations 1960;

 

substitute:

 

National Health (Pharmaceutical Benefits) Regulations 2017;

 

 

[18] Section 11A - Writing of prescriptions – prescriptions other than medication chart prescriptions (paragraph 11A(1)(e))

 

omit:

 

regulation 8A of the National Health Act 1953;

 

substitute:

 

section 16 of the National Health (Pharmaceutical Benefits) Regulations 2017;

 

 

[19] Section 11A -Writing of prescriptions – prescriptions other than medication chart prescriptions (paragraph 11A(1)(i))

 

omit:

 

(as defined in the National Health (Pharmaceutical Benefits) Regulations 1960)

 

substitute:

 

(as defined in the National Health (Pharmaceutical Benefits) Regulations 2017)

 

 

[20] Section 16 - Supply of Pharmaceutical Benefits – Procedure by Community Pharmacists (the Note to the section)

 

omit:

 

National Health (Pharmaceutical Benefits) Regulations 1960.

 

substitute:

 

National Health (Pharmaceutical Benefits) Regulations 2017.

 

 

[21] Section 16AA - Supply of pharmaceutical benefit on basis of medication chart prescription (subparagraph 16AA(2)(c)(i))

 

omit:

 

regulation 8A of the National Health (Pharmaceutical Benefits) Regulations 1960;

 

substitute:

 

section 16 of the National Health (Pharmaceutical Benefits) Regulations 2017;

 

 

[22] Section 16A - When Pharmaceutical benefits may be supplied by Community Pharmacists without prescription (paragraph 16A(4)(a))

 

omit:

 

regulation 8A of the National Health (Pharmaceutical Benefits) Regulations 1960;

 

substitute:

 

section 16 of the National Health (Pharmaceutical Benefits) Regulations 2017;

 

 

[23] Section 16A - When Pharmaceutical benefits may be supplied by Community Pharmacists without prescription (subsection 16A(8))

 

omit:

 

subregulation 25(2) of the National Health (Pharmaceutical Benefits) Regulations 1960

 

substitute:

 

subsection 51(2) of the National Health (Pharmaceutical Benefits) Regulations 2017

 

 

[24] Section 45 – Keeping documents – other than for continued dispensing or medication chart prescriptions (after subsection 45(2))

 

insert, at the end of the section:

 

Note: The document may be kept in an electronic form (see subsection 12(2) of the Electronic Transactions Act 1999).

 

 

[25] Section 45A – Keeping documents – continued dispensing

 

insert, at the end of the section:

 

Note: The information may be kept in an electronic form (see subsection 12(2) of the Electronic Transactions Act 1999).

 

 

[26] Section 45B – Keeping documents – medication chart prescriptions

 

insert, at the end of the section:

 

Note: The document may be kept in an electronic form (see subsection 12(2) of the Electronic Transactions Act 1999).